Pipeline Therapeutics

company

About

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$32M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases. The company's therapies leverage the natural repair process in several different nervous system cell types to target diseases such as multiple sclerosis, providing patients with a treatment to repair damage to the nervous system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$112M
Pipeline Therapeutics has raised a total of $112M in funding over 2 rounds. Their latest funding was raised on Feb 11, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 11, 2021 Series C $80M 1 Detail
Dec 18, 2019 Series B $32M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Pipeline Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series C